TODAY'S HEADLINES

Serious risks associated with SGLT2 inhibitors

FDA is warning about ketoacidosis and urinary tract infections associated with the relatively new class of type 2 diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. Read more

FDA approves first drug for adults, children with rare enzyme disorder

Genetically engineered chickens were needed to produce Kanuma (sebelipase alfa), newly approved by the FDA to treat lysosomal acid lipase deficiency (LAL-D), a genetic and progressive ultra-rare metabolic disease in which patients suffer multi-organ damage and premature death. Read more

CONTINUING PHARMACY EDUCATION

MTM essentials for cough management

Pharmacists can help patients with the various management options for the most common causes of cough. More

EDITOR'S PICK

Two states to allow pharmacists to prescribe birth control

Pharmacists in California and Oregon will soon be able to prescribe birth control. Details

December 16, 2015

Related Articles

SGLT2 inhibitors for diabetes may cause ketoacidosis, FDA warns

FDA approves drug to treat rare bile acid synthesis disorders in kids, adults